Source comparison
AOD-9604 Before and After Real Results: Comparison by Protocol
Monash Phase 2a 1mg SC daily 12 weeks 2.6kg (6.8% reduction) No significant change Mild injection-site erythema in 12% Most robust clinical evidence. Reproducible but modest fat loss with preserved lean mass Pilot Dose-Ranging Study 0.5mg, 1mg, 2mg SC daily 8
This comparison does not assign a generated winner or score.
- Monash Phase 2a
- 1mg SC daily
- 12 weeks
- 2.6kg (6.8% reduction)
- No significant change
- Mild injection-site erythema in 12%
- Most robust clinical evidence. Reproducible but modest fat loss with preserved lean mass
- Pilot Dose-Ranging Study
- 0.5mg, 1mg, 2mg SC daily
- 8 weeks
- 1.8kg at 0.5mg, 2.9kg at 1mg, 2.7kg at 2mg
- Erythema increased at 2mg dose
- Dose-response ceiling observed at 1mg. Higher doses add no benefit
- Anecdotal Reddit Protocol (300mcg BID)
- 300mcg SC twice daily
- Self-reported 8–12lb loss (unverified)
- Not measured
- Not systematically tracked
- Uncontrolled data. No DEXA verification, confounded by diet and training variables
- Stacked Protocol (AOD + Ipamorelin)
- 1mg AOD + 200mcg Ipa daily
- 10 weeks
- Not published
- No controlled trial data. Mechanistic rationale exists but efficacy unverified